A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease
Clinical trial NCT01733992 · COMPLETED
Trial details
- NCT number
- NCT01733992
- Sponsor
- Rigel Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-02-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.